Bone, Journal Year: 2024, Volume and Issue: unknown, P. 117384 - 117384
Published: Dec. 1, 2024
Language: Английский
Bone, Journal Year: 2024, Volume and Issue: unknown, P. 117384 - 117384
Published: Dec. 1, 2024
Language: Английский
International Journal of Molecular Sciences, Journal Year: 2025, Volume and Issue: 26(2), P. 848 - 848
Published: Jan. 20, 2025
Tanshinones, biologically active diterpene compounds derived from Salvia miltiorrhiza, interact with specific proteins and DNA sequences, influencing signaling pathways in animals humans. This study highlights tanshinone–protein interactions observed at concentrations achievable vivo, ensuring greater physiological relevance compared to vitro studies that often employ supraphysiological ligand levels. Experimental data suggest while tanshinones multiple proteomic targets, only a few enzymes are significantly affected relevant concentrations. apparent paradox may be resolved by tanshinones’ ability bind influence involved gene expression or mRNA stability, such as RNA polymerase II human antigen R protein. These trigger secondary, widespread changes expression, leading complex alterations. Although the current understanding of remains incomplete, this provides foundation for deciphering molecular mechanisms underlying therapeutic effects S. miltiorrhiza diterpenes. Additionally, numerous tanshinone derivatives have been developed enhance pharmacokinetic properties biological activity. However, their safety profiles remain poorly characterized, limiting comprehensive insights into medicinal potential. Further investigation is essential fully elucidate toxicological both native modified tanshinones.
Language: Английский
Citations
0Journal of Cellular and Molecular Medicine, Journal Year: 2025, Volume and Issue: 29(5)
Published: Feb. 27, 2025
ABSTRACT Ferroptosis plays a crucial role in the pathogenesis of osteoarthritis (OA), and inhibition chondrocyte ferroptosis effectively alleviates OA progression. Krüppel‐like factor 9 (KLF9) is demonstrated to be upregulated OA, but its molecular mechanism remains unclear. The study aimed investigate KLF9 Primary chondrocytes were treated with IL‐1β establish an cell model, showed that was highly expressed IL‐1β‐incubated chondrocytes. Knockdown alleviated IL‐1β‐induced degeneration. In addition, decreased methylation proportion gene promoter. DNA methyltransferase 1 (DNMT1) directly bound promoter, overexpression DNMT1 inhibited expression by promoting promoter Subsequently, shRNA pcDNA‐CYP1B1 individually or altogether transfected into Cytochrome P450 1B1 (CYP1B1) chondrocytes, abrogated inhibitory effect on ferroptosis. Moreover, Ferrostatin‐1 (Fer‐1, inhibitor ferroptosis) reversed promotion Finally, vivo experiments significantly suppressed cartilage tissue damage, ferroptosis, IHC scores CYP1B1 rats. conclusion, our results suggested KLF9, epigenetic silenced DNMT1, promoted extracellular signal‐regulated kinase (ERK)‐mediated through transcriptionally regulating CYP1B1. Thus, expected new target for treatment OA.
Language: Английский
Citations
0Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, Journal Year: 2025, Volume and Issue: 1871(5), P. 167766 - 167766
Published: March 3, 2025
Language: Английский
Citations
0International Journal of Molecular Sciences, Journal Year: 2025, Volume and Issue: 26(6), P. 2667 - 2667
Published: March 16, 2025
Cardiovascular disease (CVD) is a serious global health issue with high mortality rates worldwide. Despite the numerous advancements in study of CVD pathogenesis recent years, further summarization and elaboration specific molecular pathways are required. An extensive body research has been conducted to elucidate association between MAPK signaling pathway, which present all eukaryotic organisms, cardiovascular disease. This review aims provide comprehensive summary on over past five years. The primary focus four diseases: heart failure, atherosclerosis, myocardial ischemia–reperfusion injury, cardiac hypertrophy. will also address pathophysiological mechanisms diseases, objective proposing novel clinical treatment strategies for CVD.
Language: Английский
Citations
0Bone, Journal Year: 2024, Volume and Issue: unknown, P. 117384 - 117384
Published: Dec. 1, 2024
Language: Английский
Citations
0